The Scientist - Home

From travel restrictions and publishing bans to currency collapse, the restoration of US sanctions has left researchers in Iran reeling.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

A brain-activated, bone-derived hormone called osteocalcin regulates the acute stress response in rodents and possibly humans.

The agency plans to stop funding virtually all toxicology studies in mammals by 2035.

Scientists show the approach can kill cells that cause hardening of heart tissue in mice.

The same study also finds there are three species of Electrophorus, rather than one.

The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.

The facility, focused on finding treatments for mental health disorders, will be the first of its kind in the US.

The new policy will increase scrutiny and pressure on stem cell clinics, according to industry experts.

Patients who suffer a traumatic brain injury may exhibit abnormally abundant tau protein many years later, a new in vivo imaging technique reveals.

A Chicago-based center that has long operated a clinical trial program for stem cell therapies, has stopped recruiting further patients as its chief, Richard Burt, leaves for a research sabbatical.

Owner Huang Yu dug up his deceased cat to give its cells to the pet-cloning company Sinogene.